A lot of smart people on this board got the "idea" right. This test just makes sense. The latest colonoscopy data confirms that even early pregen versions had accuracy competitive with this so-called "gold standard". Yet medical community politics, government bureaucrats and substandard management kicked our ass.
I may still may take a position here. Good luck with your bet.
Sold my remaining shares from $1.50 down to around $1.10. So many head fakes with this thing it's hard to tell what to do. Since the IPO the right move has been to stay far away. Like the technology, hate the management so I'll just keep watching.